Evolution of central nervous system multidrug-resistant Mycobacterium tuberculosis and late relapse of cryptic prosthetic hip joint tuberculosis: Complications during treatment of disseminated isoniazid-resistant tuberculosis in an immunocompromised host

Journal of Clinical Microbiology

Volumn 47, Issue 2, 2009, Pages 507-510

  Upton, Arlo ^a,c   Woodhouse, Andrew ^a,d   Vaughan, Ross ^a   Newton, Sandie ^a   Ellis Pegler, Rod ^a,b  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Medical Specialists' Group   (New Zealand)

^c Auckland Clinical Studies   (New Zealand)

^d OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZATHIOPRINE; CAPREOMYCIN; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; PREDNISONE; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM ISOLATION; BONE BIOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG SENSITIVITY; HIP PROSTHESIS; HUMAN; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; CEREBROSPINAL FLUID; CHEMISTRY; DRUG EFFECT; HIP; IMMUNE DEFICIENCY; INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; RECURRENT DISEASE; SERUM; TUBERCULOUS MENINGITIS;

MYCOBACTERIUM TUBERCULOSIS;

ADULT; ANTITUBERCULAR AGENTS; CEREBROSPINAL FLUID; HIP JOINT; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYCOBACTERIUM TUBERCULOSIS; PROSTHESIS-RELATED INFECTIONS; RECURRENCE; SERUM; TUBERCULOSIS, MENINGEAL; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 60849097236     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01473-08     Document Type: Article

References (12)

1. Anonymous. 2008. The rise and spread of drug-resistant tuberculosis. Lancet 371:698.
2. Barco, P., R. F. Cardoso, R. D. Hirata, C. Q. Leite, J. R. Padndolfi, D. N. Sato, M. L. Shikama, F. F. de Melo, E. M. Mamizuka, P. A. Campanerut, and M. H. Hirata. 2006. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J. Antimicrob. Chemother. 58:930-935.
3. Berbari, E. F., A. D. Hanssen, M. C. Duffy, J. M. Steckelberg, and D. R. Osnon. 1998. Prosthetic joint infection due to Mycobacterium tuberculosis: a case series and review of the literature. Am. J. Orthop. 27:219-227.
4. Berning, S. E., T. A. Cherry, and M. D. Iseman. 2001. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin. Infect. Dis. 32:643-646.
5. DeVincenzo, J. P., S. E. Berning, C. A. Peloquin, and R. N. Husson. 1999. Multidrug-resistant tuberculous meningitis: clinical problems and concentrations of second-line antituberculous medications. Ann. Pharmacother. 33:1184-1188.
6. Ellard, G. A., M. J. Humphries, and B. W. Allen. 1993. Cerebrospinal fluid drug concentrations and the treatment of tuberculous meningitis. Am. Rev. Respir. Dis. 148:650-655.
7. Peloquin, C. A. 1997. Using therapeutic drug monitoring to dose the antimycobacterial drugs. Clin. Chest Med. 18:79-87.
8. Pfyffer, G. E., F. Palicova, and S. Rusch-Gerdes. 2002. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system. J. Clin. Microbiol. 40:1670-1674.
9. Pletz, M. W., A. De Roux, A. Roth, K. H. Neumann, H. Mauch, and H. Lode. 2004. Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective randomized study. Antimicrob. Agents Chemother. 48:780-782.
10. Rossau, R., H. Traore, H. De Beenhouwer, W. Mijs, G. Jannes, P. De Rijk, and F. Portaels. 1997. Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob. Agents Chemother. 41:2093-2098.
11. Spinner, R. J., D. J. Sexton, R. D. Goldner, and L. S. Levin. 1996. Periprosthetic infections due to Mycobacterium tuberculosis in patients with no prior history of tuberculosis. J. Arthroplasty 11:217-222.
12. van Embden, J. D., M. D. Cave, J. T. Crawford, J. W. Dale, K. D. Eisenach, B. Gicquel, P. Hermans, C. Martin, R. McAdam, and T. M. Shrinick. 1993. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J. Clin. Microbiol. 31:406-409.